About the Center

Schedule a Virtual Visit

Our dedicated physicians, nurses and staff are committed to providing the best possible care for our patients. We have taken unprecedented steps to ensure office visits and procedures are welcoming and safe. Your/your child's health and safety is our top priority. Our center is invested in providing resources for patients with celiac disease during these challenging times, and collecting preliminary data on COVID-19 and celiac disease. Learn more.

Our team provides patients with virtual visits using video-based programs over a secure Internet connection to the patient’s desktop computer, laptop or tablet. Virtual visits give our patients and families a direct video link with their doctor without having to travel for an appointment. Patients may discuss symptoms and clarify treatment plans from the comfort of their home or another private setting. To arrange a virtual visit, please call 617-726-8705.

Learn more about virtual visits  

Our Commitment

The Center for Celiac Research and Treatment is dedicated to improving the quality of life for patients with celiac disease, while learning the cause of the disease and finding a cure. The Center provides comprehensive clinical care and long-term support for adults and children who suffer from celiac disease. Celiac disease, a genetically based autoimmune disease, affects 1 out of every 133 people in the United States. Learn more about the mission of the Center for Celiac Research and Treatment.

Patient Resources

View the full collection of patient resources from the Center for Celiac Research and Treatment.

Provider Resources

View the full collection of provider resources from the Center for Celiac Research and Treatment.

Celiac Disease Research

Through ongoing research and clinical trials, the Center is helping health care professionals to recognize celiac disease and helping patients with celiac disease to better manage their symptoms.

Center scientists are working to develop a cure and an alternative treatment to the gluten-free diet. In addition, the Center is investigating possible links between celiac disease and other autoimmune diseases.

Center Currently Recruiting Newborns to Study Celiac Disease

The Center for Celiac Research and Treatment at MGfC is currently recruiting for an exciting research study known as the CDGEMM study. Newborns and infants who have a first-degree relative (father, mother or sibling) with diagnosed celiac disease are eligible to participate. This multi-center effort is aimed at identifying patterns in gut bacteria that may one day be able to predict and/or prevent the onset of celiac disease.

A 14-Day Gluten Challenge Research Study

What happens to a celiac patient if or when they are re-exposed to gluten? Researchers are uncovering answers through a number of initiatives, including exposing study participants to gluten during a 14-day challenge. The center is enrolling patients ages 18 to 75 with biopsy-proven celiac disease who have been on a gluten-free diet for at least 6 months. Participation includes six visits over 15 weeks.

Read more about this participant's experience in the study »

Here's one patient's story from symptoms to diagnosis to treatment »

Mucosal Immunology and Biology Research Center

The Mucosal Immunology and Biology Research Center (MIBRC) conducts basic research in the field of mucosal immunology. Currently, primary investigators work on related issues ranging from Salmonella food poisoning to intestinal inflammatory diseases and the associated immune-mediated conditions. Learn more about the Mucosal Immunology and Biology Research Center.

State-of-the-Art Treatment

Led by Dr. Alessio Fasano, the Center includes a multidisciplinary team of gastroenterologists, pediatricians, dietitians and nurses who work together to develop individualized treatment plans for people with celiac disease.

Patients with celiac disease and their families also receive lifestyle counseling and dietary support to help them avoid foods containing gluten.

Read about this patient's treatment experience after transferring care to Mass General »